BB&T cuts entire ER department

http://www.cnbc.com/2016/07/28/bbt-cuts-jobs-as-i…

Surprised that this wasn't here already. But for any aspiring equity researchers (looking at those ppl who've messaged me as of late asking for advice), this is the risk of entering a field in decline. I remember BB&T was hiring not all that long ago (~1 yr ago) and whichever unlucky person got it ended up getting the really short end of the stick.

Now this isn't to say that sell-side ER is vanishing altogether. People who say that largely don't know what they're talking about. Having said that, the pain is real and breaking into the industry through a smaller regional shop potentially exposes an individual to unpredictable, binary eventualities such as this one.

In happier news... at least it's Friday. Cheers!

 

While there are cyclical trends in ER, there are ongoing, permanent reductions in industry wide headcount. Plenty of high ranked shops are also laying people off and having the survivors either pick up more coverage, or just dropping less profitable names altogether (either from an IBD or trading perspective), Obviously, the situation at BB&T is not a 'cyclical' development and as other smaller shops follow suit (e.g. Sterne Agee), there'll be an oversupply of ER professionals with nowhere to go.

However, as with all things, eventually we'll reach some equilibrium and hopefully the environment is a lot less depressing then. When this will come about and where the industry will ultimately end up though, I have no idea.

 
Best Response
Now this isn't to say that sell-side ER is vanishing altogether. People who say that largely don't know what they're talking about.

It may not be "vanishing altogether," but it is in serious decline and will continue to decline for many years. There are way too many brokers out there and headcount must go down significantly.

as with all things, eventually we'll reach some equilibrium and hopefully the environment is a lot less depressing then. When this will come about and where the industry will ultimately end up though, I have no idea.

100% agree. Unfortunately I don't see an end in sight. Maybe in 5-10 years after 50-70% of headcount leaves the industry. What people need to grasp is that the equity research revenue just isn't coming back. Soft dollars are going way down.

Where do you think these oversupply ER professionals will likely end up?

I've seen some enter the industry they previously covered. A classic exit route is going into investor relations. The problem is the compensation differential is huge.

 

Ut facilis facilis non repellendus. Magnam a possimus deleniti cum quisquam quaerat. Ullam vel sint quibusdam id aut.

Tenetur accusantium modi ut quaerat. Quia consequatur mollitia ex quo libero cumque. Omnis et voluptate dolor facere doloribus doloremque. Ex ut est sunt debitis ut eum voluptas. Nam qui et ipsa et at rerum. Facere quas sed ipsam nobis officia. Est sit reiciendis molestias molestiae ipsam non.

Nulla velit dolorem ducimus dolores voluptatem voluptatem officia iure. Possimus dolorem magnam a ut autem omnis. Ea dolorem error non magnam. Quos aut dolor mollitia sit sit dolore deleniti.

Nam distinctio fugit velit facere dicta laboriosam quam. Dolores eos nihil eius eos sint consectetur quia. Dolorem deleniti nostrum omnis cum quia et.

Career Advancement Opportunities

March 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. (++) 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

March 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

March 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

March 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (86) $261
  • 3rd+ Year Analyst (13) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (202) $159
  • Intern/Summer Analyst (144) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”